Chase Knickerbocker
Stock Analyst at Craig-Hallum
(1.36)
# 1790
Out of 5,370 analysts
42
Total ratings
50.00%
Success rate
13.18%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NRXS Neuraxis | Initiates Coverage On: Buy | 7 | 2.55 | 174.51% | 1 | Jun 16, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Strong Buy | 12 17 | 10.6 | 60.38% | 2 | Jun 9, 2025 | |
FENC Fennec Pharmaceutica... | Maintains: Strong Buy | 12 13 | 8.08 | 60.89% | 5 | May 14, 2025 | |
ETON Eton Pharmaceuticals | Maintains: Strong Buy | 26 28 | 14.24 | 96.63% | 6 | May 14, 2025 | |
XERS Xeris Biopharma Hold... | Maintains: Strong Buy | 5 7 | 4.41 | 47.39% | 1 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 39 | 20.58 | 89.5% | 1 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 0.68 | 1076.47% | 4 | Jan 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 18 21 | 15.39 | 36.45% | 2 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 6 | 3.25 | 84.62% | 2 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 12 | 3.98 | 201.51% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 3.67 | 172.48% | 1 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 16 | 14.19 | 12.76% | 3 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 45 65 | 31.53 | 106.15% | 3 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | n/a | n/a | 2 | Sep 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 12 | 5.98 | 100.67% | 2 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 7.73 | 29.37% | 1 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 23 | 9.48 | 142.62% | 2 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1 2 | 0.63 | 90.48% | 2 | Jul 11, 2023 |